Ticker Details
Kezar Life Sciences, Inc.
IPO Date:	June 18, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$54.18M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.23 | 3.13%
Avg Daily Range (30 D):	$0.11 | 1.65%
Avg Daily Range (90 D):	$0.07 | 1.13%

Institutional Daily Volume
Avg Daily Volume:	.15M
Avg Daily Volume (30 D):	.07M
Avg Daily Volume (90 D):	.05M

Trade Size
Avg Trade Size (Sh.):	47
Avg Trade Size (Sh.) (30 D):	170
Avg Trade Size (Sh.) (90 D):	151

Institutional Trades
Total Institutional Trades:	544
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$.69M
Avg Institutional Trade (90 D):	$.69M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.61M
Avg Closing Trade (30 D):	$4.17M
Avg Closing Trade (90 D):	$4.17M
Avg Closing Volume:	23.01K

News

Oct 17, 2025 @ 6:38 PM Kezar Launches Strategic Review As FDA Roadblock D... Source: Vandana Singh

Oct 5, 2023 @ 3:00 PM Benzinga's Top Ratings Upgrades, Downgrades For Oc... Source: Benzinga Insights

Oct 4, 2023 @ 1:32 PM Kezar (KZR) Falls 10% on Strategic Update, Reduces... Source: Zacks Equity Research

Sep 21, 2023 @ 11:51 AM Why Murphy Canyon Acquisition Shares Are Trading H... Source: Lisa Levin

Sep 21, 2023 @ 10:48 AM The economy is about to slow down. That's the time... Source: MarketWatch

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-7.66	$-1.99	$-7.66
Diluted EPS	$-7.66	$-1.99	$-7.66
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-56.03M	$-14.55M	$-56.03M
Operating Income / Loss	$-59.11M	$-15.16M	$-59.11M
Cost of Revenue
Net Cash Flow	$30.13M	$32.94M	$30.13M
PE Ratio

Splits
Oct 30, 2024	1:10